CN103980261B — 卡格列净的a晶型及其结晶制备方法
Assigned to Tianjin University · Expires 2016-06-29 · 10y expired
What this patent protects
本发明公开了一种卡格列净的A晶型及其结晶制备方法,其X-射线粉末衍射图谱在衍射角2θ=3.7±0.1,3.9±0.1,7.7±0.1,7.9±0.1,11.5±0.1,13.1±0.1,13.5±0.1,14.3±0.1,15.5±0.1,17.3±0.1,18.8±0.1,19.3±0.1,20.3±0.1,22.5±0.1,22.7±0.1,23.2±0.1和23.4±0.1度处有特征峰。本发明操作步骤简单易操作、耗时短、耗能少。制备出的产品稳定性好,纯度高于99%、收率90%左右,产品在常温、干燥条件下储存100天后,产品纯度、颜色、形态未发生变化…
USPTO Abstract
本发明公开了一种卡格列净的A晶型及其结晶制备方法,其X-射线粉末衍射图谱在衍射角2θ=3.7±0.1,3.9±0.1,7.7±0.1,7.9±0.1,11.5±0.1,13.1±0.1,13.5±0.1,14.3±0.1,15.5±0.1,17.3±0.1,18.8±0.1,19.3±0.1,20.3±0.1,22.5±0.1,22.7±0.1,23.2±0.1和23.4±0.1度处有特征峰。本发明操作步骤简单易操作、耗时短、耗能少。制备出的产品稳定性好,纯度高于99%、收率90%左右,产品在常温、干燥条件下储存100天后,产品纯度、颜色、形态未发生变化。
Drugs covered by this patent
- Invokana (CANAGLIFLOZIN) · Johnson & Johnson
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.